Jason Karlawish, M.D.
Professor of Medicine
Fellow, Institute on Aging, University of Pennsylvania
Senior Fellow, Center for Bioethics, University of Pennsylvania School of Medicine
Associate Director, Penn Memory Center (Core B, Alzheimer's Disease Center), University of Pennsylvania
Director, Education, Recruitment and Retention Core (Core E, Alzheimer's Disease Center) , University of Pennsylvania
Attending Physician, Penn Memory Center 1 afternoon/week
Senior Fellow, Leonard Davis Institute, University of Pennsylvania
Faculty, Penn Center for Neuroscience and Society, University of Pennsylvania
Director, Penn Neurodegenerative Disease Ethics and Policy Program, University of Pennsylvania
(Honors Program in Medical Education)
Northwestern University, 1987.
Northwestern University School of Medicine, 1991.
Intern in Medicine, Francis Scott Key Hospital, Baltimore, 1991-1992.
Resident in Medicine, Francis Scott Key Hospital, Baltimore, 1992-1994.
Fellow, Clinical Medical Ethics, University of Chicago, Chicago, 1994-1995.
Fellow, Geriatric Medicine, University of Chicago, Chicago, 1995-1997.
Recertification American Board of Internal Medicine (original certification 1994), 2004.
Recertification of Added Qualifications in Geriatric Medicine (1998 original certification), 2008.
Trojanowski JQ, Arnold SE, Karlawish JH, Naylor M, Brunden KR, Lee VM-Y: A model for improving the treatment and care of Alzheimer patients through interdisciplinary research. Alzheimer's & Dementia 8(6): 564-573, Nov 2012.
Jefferson AL, Carmona H, Gifford K, Sarinana SL, Byerly LK, Cantwell N, Tripodis Y, Karlawish J: Clinical Research Risk Assessment Among Individuals with Mild Cognitive Impairment. American Journal of Geriatric Psychiatry 20(10): 878-886, Oct 2012.
Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM-Y, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, Feinberg LF, Frisoni G, Green C, Guimaraes RM, Gwyther LP, Hefti FF, Hutton M, Kawas C, Kent DM, Kuller L, Langa KM, Mahley RW, Maslow K, Masters CL, Meier DE, Neumann PJ, Paul SM, Petersen RC, Sager MA, Sano M, Schenk D, Soares H, Sperling RA, Stahl SM, Van Deerlin V, Stern Y, Weir D, Wolk D, Trojanowski JQ.: Advancing Alzheimer’s disease diagnosis, treatment, and care:
Recommendations from the Ware Invitational Summit. Alzheimer's and Dementia 8(5): 445-452, Sep 2012.
Kesselheim AS, Karlawish J: Biomarkers Unbound - the Supreme Court's Ruling on Diagnostic-Test Patents. New England Journal of Medicine 366(25): 2338-2340, June 2012.
Lui WCV, Lam CWL, Chau CMR, Fung WTA, Wong MLB, Leung TYG, Leung KF, Chiu FKH, Karlawish JHT, Appelbaum PS: Capacity to Make Decisions on Medication Management in Chinese Older Persons with Mild Cognitive Impairment and Mild Alzheimer Disease. International Psychogeriatrics 24(7), June 2012.
Tsou AY, Karlawish J, McCluskey L, Xie S, Long J: Predictors of emergent feeding tubes and tracheostomies in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis 13(3): 318-325, May 2012.
Karlawish J: What We Talk About When We Talk About Alzheimer’s Disease. Robert Wood Johnson Foundation Human Capital Blog. http://blog.rwjf.org/humancapital/2012/03/12/what-we-talk-about-when-we-talk-about-alzheimer%E2%80%99s-disease/ Mar 2012.
Meisel ZF, Karlawish J: Narrative vs Evidence-Based Medicine-- And, Not Or. Journal of the American Medical Association 306(18): 2022-2023, November 2011.
Karlawish J: Open Wound: The Tragic Obsession of Dr. William Beaumont. University of Michigan Press, Ann Arbor, MI August 2011.
Flory J, Karlawish J: The Prompted Optional Randomization Trial: A New Design for Comparative Effectiveness Research. American Journal of Public Health 102(12), December 2012 Notes: Drug A or Drug B? How EMR can advance the design and value of comparative effectiveness research.
Karlawish J, Sabatino C, Markowitz D, Rubright J, Klem E, Boruch RF.: Bringing the vote to the residents of long-term care facilities: A study of the benefits and challenges of mobile polling. Election Law Journal 10(1): 5-14, Mar 2011.
Sperling RA, Karlawish J, Johnson KA: Preclinical Alzheimer disease—the challenges ahead. Nature Reviews Neurology Page: 54-58, December 2012.
back to top
Last updated: 05/03/2013
The Trustees of the University of Pennsylvania